On April 18, 2024, new AV21 specification of TaurusOne® and TaurusElite® TAVR systems, developed by the Company, has been approved by the NMPA. The new specification has the following advantages: 1) Precise fit: specially designed for the smaller aortic root structure of Chinese patients 2) Large EOA: supra-annular valve design; higher radial force; lower risk of PPM 3) Waist design: ensures coronary artery safety 4) Short stent: with a stent height of 40.5mm, it poses a low risk of ascending aorta dissection after implantation.